Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenergic blockade after stroke. A preliminary closed cohort study.

G Kinnander, M Viitanen, K Asplund

    Stroke
    |January 1, 1987
    PubMed
    Summary

    Beta-blocker therapy may reduce long-term mortality and recurrent strokes after stroke. Further research is needed to confirm these findings for patients with cerebrovascular disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Use of oral anticoagulants after ischaemic stroke in patients with atrial fibrillation and cancer.

    Journal of internal medicine·2020
    Same author

    Impact of the Swedish National Stroke Campaign on stroke awareness.

    Acta neurologica Scandinavica·2017
    Same author

    Primary familial brain calcification linked to deletion of 5' noncoding region of SLC20A2.

    Acta neurologica Scandinavica·2016
    Same author

    APOE and AGT in the Finnish p.Arg133Cys CADASIL population.

    Acta neurologica Scandinavica·2015
    Same author

    The controversial snuff.

    Journal of internal medicine·2014
    Same author

    [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment.

    European journal of nuclear medicine and molecular imaging·2013

    Area of Science:

    • Neurology
    • Cardiology

    Background:

    • Stroke is a leading cause of death and disability.
    • Beta-blockers are commonly used for cardiovascular conditions.
    • The role of beta-blockers in post-stroke prognosis is not fully established.

    Purpose of the Study:

    • To evaluate the long-term effects of beta-blocker therapy on mortality and recurrent strokes in patients discharged after a stroke.
    • To gather preliminary data for a prospective clinical trial on beta-blockers for stroke prevention.

    Main Methods:

    • A retrospective comparison of 60 patients on beta-blockers versus 60 matched controls not on beta-blockers.
    • Matching criteria included sex, age, stroke type, hypertension, and cardiac failure.
    • Follow-up duration was a median of 41 months for the beta-blocker group and 36 months for the control group.

    Related Experiment Videos

    Main Results:

    • The beta-blocker group had a lower mortality rate (22%) compared to the control group (35%).
    • The relative risk of death was 0.60 (p=0.14) in the beta-blocker group.
    • Recurrent strokes were less frequent in the beta-blocker group (relative risk 0.57, p=0.12).

    Conclusions:

    • Beta-blocker therapy showed a trend towards reduced mortality and recurrent strokes after stroke.
    • The observed benefits were not solely due to fewer myocardial infarction deaths.
    • More extensive research is required to confirm the efficacy of beta-blockers in managing patients with cerebrovascular disease.